한글목차

세계의 메디컬 에스테틱 시장 규모는 2024년 1,716만 달러에서 2030년에는 353억 2,000만 달러에 달하며, 예측 기간 중 CAGR은 12.8%에 달할 것으로 예측됩니다.

메디컬 에스테틱 시장의 성장은 몇개의 요인에 의해 촉진되고 있습니다. 우선 수요 측면에서 저침습 및 비침습적 치료는 부작용 위험 감소 및 회복 기간 단축과 같은 기존 방법에 비해 몇 가지 장점이 있으므로 점점 더 많은 수요가 증가하고 있습니다. 다기능 레이저 및 다양한 피부 회춘 기술을 포함한 미용 기술의 발전은 이러한 치료의 효과와 정확성을 높이고 더 나은 결과를 창출하고 더 많은 사람들에게 혜택을 제공함으로써 시장에 더 친숙하고 매력적으로 다가갈 것으로 예상됩니다. 미용 시술 시장은 개발도상국의 가처분 소득 증가로 인해 완화되고 있습니다. 웰빙, 자기 관리, 소셜미디어에 대한 관심이 높아지면서 젊음을 유지하기 위해 미용 시술을 받으려는 사람들 수요가 증가하고 있습니다. 또 다른 촉진요인으로는 선진국의 고령화로 인해 다양한 문제에 대한 안티에이징 솔루션을 찾는 사람들이 증가하고 있습니다. 이러한 요인들은 모두 메디컬 에스테틱 시장의 성장에 기여하고 있습니다.

메디컬 에스테틱 시장은 2023년 페이셜 에스테틱 제품 부문에서 가장 큰 점유율을 차지했습니다. 이 부문은 페이셜 에스테틱 제품, 미용 임플란트, 피부 미용 장비, 바디 컨투어링 장비, 의사 조제 화장품, 스킨 라이트너, 실 리프팅 제품, 제모 장비, 문신 제거 장비, 의사 조제 속눈썹 제품, 네일 치료 레이저 기기 등을 취급합니다. 페이셜 에스테틱 제품의 대부분은 보톡스, 더말 필러와 같은 얼굴 회춘을 위한 비침습적 치료법입니다. 이러한 제품들은 자연스러운 외관과 최소한의 다운타임으로 효과적인 결과를 얻을 수 있는 능력으로 인해 더욱 선호되고 있습니다. 또한 집에서 할 수 있는 미용 시술에 대한 수요가 증가함에 따라 시장은 더욱 성장할 것으로 예상됩니다. 이러한 재택 치료로의 전환은 사용자 친화적인 첨단 장비의 가용성 덕분에 가능했으며, 이는 페이셜 에스테틱 솔루션의 접근성과 경제성을 확대하는 데 기여하고 있습니다. 이에 따라 페이셜 에스테틱 제품 부문은 편리하고 효과적인 에스테틱 강화에 대한 소비자 선호에 따라 가장 빠른 속도로 성장세를 이어갈 것으로 예상됩니다.

세계의 메디컬 에스테틱 시장에 대해 조사했으며, 제품별, 기기 유형별, 시술법별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 개요

제4장 주요 인사이트

제5장 시장 개요

• 서론
• 시장 역학
• 고객 비즈니스에 영향을 미치는 동향/혼란
• 가격 분석
• 밸류체인 분석
• 공급망 분석
• 에코시스템 분석
• 투자와 자금조달 시나리오
• 기술 분석
• 특허 분석
• 무역 분석
• 2025-2026년의 주요 컨퍼런스와 이벤트
• 사례 연구 분석
• 규제 상황
• Porter's Five Forces 분석
• 주요 이해관계자와 구입 기준
• 미충족 요구
• AI/생성형 AI가 메디컬 에스테틱 시장에 미치는 영향

제6장 메디컬 에스테틱 시장, 제품별

• 서론
• 페이셜 에스테틱 제품
• 보디 컨투어링 디바이스
• 미용 임플란트
• 의사 처방 화장품 및 미백제
• 스킨 에스테틱 기기
• 의사 처방 속눈썹 제품
• 제모기
• 문신 제거 기기
• 스레드 리프트 제품
• 네일 치료 레이저 기기
• 홈케어 기기

제7장 메디컬 에스테틱 시장, 기기 유형별

• 서론
• 스탠드얼론 기기
• 멀티모달 기기
• 자택용 기기/셀프 유스 기기

제8장 메디컬 에스테틱 시장, 시술법별

• 서론
• 비외과적 시술
• 외과수술

제9장 메디컬 에스테틱 시장, 최종사용자별

• 서론
• 클리닉, 병원, 메디컬 스파
• 뷰티 센터
• 홈케어

제10장 메디컬 에스테틱 시장, 지역별

• 서론
• 북미
  • 북미의 거시경제 전망
  • 미국
  • 캐나다
• 유럽
  • 유럽의 거시경제 전망
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 기타
• 아시아태평양
  • 아시아태평양의 거시경제 전망
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 기타
• 라틴아메리카
  • 라틴아메리카의 거시경제 전망
  • 브라질
  • 멕시코
  • 기타
• 중동 및 아프리카
  • 중동 및 아프리카의 거시경제 전망
  • GCC 국가
  • 기타

제11장 경쟁 구도

• 개요
• 주요 참여 기업의 전략/강점
• 매출 분석, 2020-2023년
• 시장 점유율 분석, 2023년
• 주요 시장 기업 순위
• 기업 가치 평가와 재무 지표
• 브랜드/제품 비교
• 경쟁 시나리오

제12장 기업 개요

• 주요 참여 기업
  • ABBVIE INC.
  • GALDERMA
  • JOHNSON & JOHNSON SERVICES, INC.
  • BAUSCH HEALTH COMPANIES INC.
  • CYNOSURE LUTRONIC
  • CUTERA, INC.
  • MERZ PHARMA
  • LUMENIS BE LTD.
  • FOTONA
  • AEROLASE CORP.
  • SCITON
  • BOHUS BIOTECH AB
  • RECOSMO
  • SHARPLIGHT TECHNOLOGIES INC.
  • CANDELA CORPORATION
  • ALMA LASERS
  • EL.EN. S.P.A.
  • INMODE LTD.
  • VENUS CONCEPT
  • GC AESTHETICS
• 기타 기업
  • EVOLUS, INC.
  • ASCLEPION LASER TECHNOLOGIES
  • ASTANZA LASER
  • APYX MEDICAL
  • HUADONG MEDICINE CO., LTD.
  • MEDYTOX INC.
  • POLYTECH HEALTH & AESTHETICS GMBH
  • REVANCE AESTHETICS
  • PHOTOMEDEX
  • 2L BIO CO., LTD.

제13장 부록

영문목차

"The global medical aesthetics market is estimated to reach USD 35.32 Billion by 2030 from USD 17.16 million in 2024, at a CAGR of 12.8% during the forecast period)."

The growth of the market of medical aesthetics is very high due to several factors. First, from the demand side, minimally invasive and non-invasive treatments are increasingly demanded since they have several advantages over conventional methods, such as a decreased risk of side effects and minimum recovery periods. Advances in aesthetic technologies, including multifunctional lasers and various skin rejuvenation techniques, enhance the effectiveness and precision of these treatments with better results that would benefit more people and make them more accessible and appealing to a larger market. The market for aesthetic procedures has been eased by increased disposable incomes in the developing world. Growing emphasis on wellness, self-care, and social media has increased demand as people seek beauty treatments to stay youthful. Other drivers include an aging population in developed countries looking for anti-aging solutions to a variety of problems. These factors are all contributing to the rise in the medical aesthetics market.

"The facial aesthetic products segment held the largest share of the market in 2023."

The market for medical aesthetics captured the largest share of facial aesthetic products in 2023. This segment deals with facial aesthetic products, cosmetic implants, skin aesthetic devices, body contouring devices, physician-dispensed cosmeceuticals, skin lighteners, thread lift products, hair removal devices, tattoo removal devices, physician-dispensed eyelash products, and nail treatment laser devices. The major portion of facial aesthetic products accounts for non-invasive treatments for facial rejuvenation, such as Botox and dermal fillers. These products are preferred more because of their ability to deliver effective results with minimal downtime in a natural appearance. The market will also experience further growth because of the rising demand for aesthetic procedures that can be done at home. This shift toward at-home treatments, enabled by the availability of advanced, user-friendly devices, is contributing to the growing accessibility and affordability of facial aesthetic solutions. As a result, the facial aesthetic products segment shall remain on track to advance at the highest rate, following consumer preference for convenient and effective aesthetic enhancements.

"The lipolysis segment is projected to register the highest CAGR of the non-surgical procedures by procedure during the forecast period."

The medical aesthetics market is segmented into surgical and nonsurgical procedures. Surgical procedures account for areas of breast augmentation, rhinoplasty, facelifts, body lifts, etc, while non-surgical procedures include anti-aging and skin rejuvenation, tattoo and scar removal, hair removal, lipolysis, and many others. Among these, the lipolysis segment is anticipated to record the highest compound annual growth rate (CAGR) within the non-surgical procedures market from 2024 to 2030. Lipolysis is a non-invasive technique for reducing excess fat that is gaining immense popularity due to its ability to target particular fat deposits without surgery. Consumer spending on cosmetic treatments, especially those that will help achieve body contouring, leads to the rapid growth of this segment. This is because numerous people are opting for more affordable and effective alternatives to traditional surgery. With lipolysis now available in the market, the development of advanced devices that allow for the precise extraction of fats with minimal downtime is further enhancing the demand. An increase in body consciousness with an increased awareness of non-surgical fat-reduction options contributes to the growth of the segment. The lipolysis segment is expected to experience continued growth and remain a key player in the medical aesthetics market across the forecast period as consumers remain focused on swift, efficient, and minimally invasive treatment options

"The market in the Asia Pacific region is expected to witness the highest growth during the forecast period."

The Asia Pacific (APAC) region is anticipated to be the fastest-growing medical aesthetics market over the forecast period, mainly due to the rapid development of healthcare infrastructure, more so in emerging economies such as India and China. Moreover, investment in the respective healthcare sectors of these countries fosters the demand for advanced medical aesthetic systems, including dermatology, body contouring, and facial aesthetics. Additionally, increasing disposable incomes and the fast-expanding middle class in the region are further fueling demand for aesthetic treatments since it's a move toward skin rejuvenation, anti-aging, and cosmetic procedures.

The industry has seen the APAC region become a more significant area of interest for companies involved in medical aesthetics, where there has been an increasing focus on innovative products offered to consumers' changing preferences. Increased clinic, hospital, and medical spa coverage in the region is the accelerator for the adoption of these technologies. Increased awareness and acceptance of aesthetic treatments are expected to fuel the growth of the market soon. The APAC region is very poised to lead the medical aesthetics market with the rising healthcare infrastructure and has numerous opportunities for growth and expansion in the sector.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1-35%, Tier 2-45%, and Tier 3-20%
• By Designation: Director-level-25%, C-level-35%, and Others-40%
• By Region: North America-40%, Europe-30%, Asia Pacific-20%, Latin America-5%, Middle East and Africa-5%

The prominent players in the medical aesthetics market are AbbVie Inc. (US), Bausch Health Companies Inc. (Canada & Johnson (US), and others.

Research Coverage

This market is segmented by product, application, end-user, and region. The report discusses drivers, restraints, opportunities, and challenges affecting the medical aesthetic market. It provides the prospects of opportunities and challenges for the stakeholders, along with detailing the competitive landscape of leading players. The micro-markets are further segmented focusing on growth trends, prospects, and the contributions of these trends towards the medical aesthetic market. To this, revenue generation through different market segments shall be forecasted and their respective growth focus put together based on five major geographies.

Key Benefits of Buying this Report

This report is to be profited by new and existing players. It will provide deep information about the medical aesthetic market for them to understand any investment opportunities. The present report provides complete information on the key players and minor players. Hence, this supports effective risk analysis along with informed decisions about investment. Due to the accurate segmentation based on end-users and geographies, this report gives niche-level views of the selected market areas.

Through this report, readers get insightful views into the following parameters:

• Analysis of the key growth drivers, restraints, challenges, and opportunities influencing market growth for the medical aesthetic market. The major driving force behind the medical aesthetic market is an increase in the geriatric population. Another reason driving the growth of the market is the increasing need for accurate, and minimally invasive solutions. With customers becoming highly attuned to non-invasive alternatives, demand for modern and efficient aesthetic solutions, including multifunctional lasers and skin rejuvenation technologies, has seen a significant increase.
• Product Development/Innovation: Advanced technologies, R&D activities, and product launches in the medical aesthetics market.
• Market Development: This report will further present the regional expansion of the medical aesthetics market, focusing on the various emerging market opportunities worldwide.
• Market Diversification: The market is increasingly diversifying due to the development of innovative products, previously untapped markets, and new trends; in addition, because of significant investments in the medical aesthetics industry, contribute to its growth as well as the constant change.
• Competitive Analysis: Exhaustive study of market share, and service offering leading strategies of major players such as AbbVie Inc (US), Alma Lasers (Israel), Cynosure (US), and GALDERMA (Switzerland), among others.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Indicative list of secondary sources
    • 2.1.1.2 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Primary sources
    • 2.1.2.2 Key data from primary sources
    • 2.1.2.3 Key industry insights
    • 2.1.2.4 Breakdown of primary interviews
• 2.2 MARKET SIZE ESTIMATION METHODOLOGY
  • 2.2.1 VENDOR REVENUE-BASED MARKET ESTIMATION
  • 2.2.2 END-USER-BASED MARKET SIZE ESTIMATION
• 2.3 MARKET FORECASTING MODEL
• 2.4 DATA TRIANGULATION AND MARKET BREAKDOWN
• 2.5 RESEARCH ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 MEDICAL AESTHETICS MARKET OVERVIEW
• 4.2 MEDICAL AESTHETICS MARKET, BY PRODUCT
• 4.3 ASIA PACIFIC: MEDICAL AESTHETICS MARKET, BY END USER, 2023 (USD MILLION)
• 4.4 REGIONAL SNAPSHOT OF MEDICAL AESTHETICS MARKET

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing adoption of minimally invasive and non-invasive aesthetic procedures
    • 5.2.1.2 Growing demand for aesthetic treatments among elderly and men
    • 5.2.1.3 Rising influence of social media
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Risk of infection and safety concerns
    • 5.2.2.2 Complex regulatory framework and compliance standards
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Significant opportunities in emerging economies
    • 5.2.3.2 Launch of new technologies and products
  • 5.2.4 CHALLENGES
    • 5.2.4.1 High cost of treatments and devices
    • 5.2.4.2 Social and cultural barriers
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.4 PRICING ANALYSIS
  • 5.4.1 AVERAGE SELLING PRICE, BY PRODUCT (ENERGY-BASED DEVICES), 2023
  • 5.4.2 AVERAGE SELLING PRICE OF INJECTABLES, BY TYPE, 2021-2023
  • 5.4.3 AVERAGE SELLING PRICE OF ENERGY-BASED DEVICES, BY KEY PLAYER, 2023
  • 5.4.4 AVERAGE SELLING PRICE TREND OF ENERGY-BASED DEVICES, BY REGION, 2021-2023
• 5.5 VALUE CHAIN ANALYSIS
  • 5.5.1 R&D
  • 5.5.2 RAW MATERIAL PROCUREMENT & PRODUCT DEVELOPMENT
  • 5.5.3 MARKETING, SALES, AND DISTRIBUTION
  • 5.5.4 AFTERMARKET SERVICES
• 5.6 SUPPLY CHAIN ANALYSIS
  • 5.6.1 PROMINENT COMPANIES
  • 5.6.2 SMALL AND MEDIUM-SIZED ENTERPRISES
  • 5.6.3 END USERS
• 5.7 ECOSYSTEM ANALYSIS
• 5.8 INVESTMENT AND FUNDING SCENARIO
• 5.9 TECHNOLOGY ANALYSIS
  • 5.9.1 KEY TECHNOLOGIES
    • 5.9.1.1 Laser and light-based technologies
    • 5.9.1.2 Radiofrequency technology
    • 5.9.1.3 Ultrasound technology
  • 5.9.2 COMPLEMENTARY TECHNOLOGIES
    • 5.9.2.1 AI-powered skin analysis systems
  • 5.9.3 ADJACENT TECHNOLOGIES
    • 5.9.3.1 Regenerative medicine and stem cell therapy
• 5.10 PATENT ANALYSIS
• 5.11 TRADE ANALYSIS
  • 5.11.1 IMPORT DATA
    • 5.11.1.1 Import scenario for HS code 854370
    • 5.11.1.2 Import scenario for HS code 901320
  • 5.11.2 EXPORT DATA
    • 5.11.2.1 Export scenario for HS code 854370
    • 5.11.2.2 Export scenario for HS code 901320
• 5.12 KEY CONFERENCES AND EVENTS, 2025-2026
• 5.13 CASE STUDY ANALYSIS
  • 5.13.1 COMMERCIAL PARTNERSHIPS FOR MEDICAL AESTHETIC PRODUCT SALES
  • 5.13.2 DIVISION OF BUSINESS TO MEET CUSTOMER DEMANDS
  • 5.13.3 COLLABORATIONS WITH SMES FOR STREAMLINING LASER-BASED DEVICES
• 5.14 REGULATORY LANDSCAPE
  • 5.14.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.14.2 KEY REGULATORY GUIDELINES
    • 5.14.2.1 North America
      • 5.14.2.1.1 US
      • 5.14.2.1.2 Canada
    • 5.14.2.2 Europe
      • 5.14.2.2.1 UK
      • 5.14.2.2.2 France
      • 5.14.2.2.3 Germany
    • 5.14.2.3 Asia Pacific
      • 5.14.2.3.1 China
      • 5.14.2.3.2 Japan
      • 5.14.2.3.3 India
    • 5.14.2.4 Latin America
      • 5.14.2.4.1 Brazil
    • 5.14.2.5 Middle East & Africa
      • 5.14.2.5.1 UAE
  • 5.14.3 REGULATORY APPROVALS
• 5.15 PORTER'S FIVE FORCE ANALYSIS
  • 5.15.1 THREAT OF NEW ENTRANTS
  • 5.15.2 THREAT OF SUBSTITUTES
  • 5.15.3 BARGAINING POWER OF SUPPLIERS
  • 5.15.4 BARGAINING POWER OF BUYERS
  • 5.15.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.16.2 BUYING CRITERIA
• 5.17 UNMET NEEDS
• 5.18 IMPACT OF AI/GEN AI ON MEDICAL AESTHETICS MARKET
  • 5.18.1 INTRODUCTION
  • 5.18.2 MARKET POTENTIAL OF AI IN MEDICAL AESTHETIC APPLICATIONS
  • 5.18.3 AI USE CASES
  • 5.18.4 KEY COMPANIES IMPLEMENTING AI
  • 5.18.5 FUTURE OF AI/GEN AI IN MEDICAL AESTHETICS ECOSYSTEM

6 MEDICAL AESTHETICS MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 FACIAL AESTHETIC PRODUCTS
  • 6.2.1 BOTULINUM TOXIN
    • 6.2.1.1 Growing willingness for Botox process to boost market
  • 6.2.2 DERMAL FILLERS
    • 6.2.2.1 Natural dermal fillers
      • 6.2.2.1.1 Rising use of dermal fillers in facial contouring to support growth
    • 6.2.2.2 Synthetic dermal fillers
      • 6.2.2.2.1 Need for quick aesthetic enhancements to accelerate growth
  • 6.2.3 CHEMICAL PEELS
    • 6.2.3.1 Increasing availability of wide range of chemical peels to expedite growth
  • 6.2.4 MICRODERMABRASION
    • 6.2.4.1 Growing use of low-risk and cost-effective resurfacing methods to fuel market
• 6.3 BODY CONTOURING DEVICES
  • 6.3.1 NON-SURGICAL FAT REDUCTION DEVICES
    • 6.3.1.1 Rise in obesity cases to sustain growth
  • 6.3.2 CELLULITE REDUCTION DEVICES
    • 6.3.2.1 Increasing focus on appearances to fuel market
  • 6.3.3 LIPOSUCTION DEVICES
    • 6.3.3.1 Growing awareness about obesity-related health risks to propel market
• 6.4 COSMETIC IMPLANTS
  • 6.4.1 BREAST IMPLANTS
    • 6.4.1.1 Silicone breast implants
      • 6.4.1.1.1 Increasing number of promotional efforts and new products by leading companies to aid growth
    • 6.4.1.2 Saline breast implants
      • 6.4.1.2.1 Reduced cost of breast implants to support growth
  • 6.4.2 FACIAL IMPLANTS
    • 6.4.2.1 Growing awareness about benefits of facial implants over other contouring products to drive market
  • 6.4.3 OTHER IMPLANTS
• 6.5 PHYSICIAN-DISPENSED COSMECEUTICALS AND SKIN LIGHTENERS
  • 6.5.1 ONGOING SHIFT TOWARD DEVELOPING SAFER SKIN-LIGHTENING PRODUCTS TO FAVOR GROWTH
• 6.6 SKIN AESTHETIC DEVICES
  • 6.6.1 LASER SKIN RESURFACING DEVICES
    • 6.6.1.1 Booming geriatric population to support growth
  • 6.6.2 NON-SURGICAL SKIN TIGHTENING DEVICES
    • 6.6.2.1 Rising popularity of non-invasive methods to speed up growth
  • 6.6.3 MICRONEEDLING PRODUCTS
    • 6.6.3.1 Reduced discomfort and enhanced skin rejuvenation to augment growth
  • 6.6.4 LIGHT THERAPY DEVICES
    • 6.6.4.1 Growing use of light therapy for pain management and sleep regulation to boost market
• 6.7 PHYSICIAN-DISPENSED EYELASH PRODUCTS
  • 6.7.1 EXPANDING MIDDLE CLASS POPULATION TO ENCOURAGE GROWTH
• 6.8 HAIR REMOVAL DEVICES
  • 6.8.1 LASER HAIR REMOVAL DEVICES
    • 6.8.1.1 Increasing availability of user-friendly home-use laser devices to spur growth
  • 6.8.2 IPL HAIR REMOVAL DEVICES
    • 6.8.2.1 Growing interest in cosmetic treatments to fuel market
• 6.9 TATTOO REMOVAL DEVICES
  • 6.9.1 NEED FOR MINIMIZED SKIN DAMAGE TO FAVOR GROWTH
• 6.10 THREAD LIFT PRODUCTS
  • 6.10.1 RISING PREFERENCE FOR MINIMAL RECOVERY TIME AND QUICK RESULTS TO STIMULATE GROWTH
• 6.11 NAIL TREATMENT LASER DEVICES
  • 6.11.1 INCREASING DEMAND FOR QUICK AND PAINLESS PROCEDURE TO PROMOTE GROWTH
• 6.12 HOME CARE DEVICES
  • 6.12.1 GROWING DEMAND FOR AFFORDABLE AND CONVENIENT HOME-BASED TREATMENTS TO DRIVE MARKET

7 MEDICAL AESTHETICS MARKET, BY TYPE OF DEVICE

• 7.1 INTRODUCTION
• 7.2 STANDALONE DEVICES
  • 7.2.1 INCREASING INNOVATIONS IN ENERGY-BASED TECHNOLOGIES TO DRIVE MARKET
• 7.3 MULTIMODAL DEVICES
  • 7.3.1 GROWING AVAILABILITY OF PERSONALIZED CARE AND TAILORED TREATMENT TO PROPEL MARKET
• 7.4 AT-HOME/SELF-USE DEVICES
  • 7.4.1 RISING FOCUS ON ENHANCED SKIN HEALTH TO FACILITATE GROWTH

8 MEDICAL AESTHETICS MARKET, BY PROCEDURE

• 8.1 INTRODUCTION
• 8.2 NON-SURGICAL PROCEDURES
  • 8.2.1 ANTI-AGING AND SKIN REJUVENATION
    • 8.2.1.1 Rising preference for maintaining youthful appearance to promote growth
  • 8.2.2 TATTOO REMOVAL
    • 8.2.2.1 Increased accessibility to tattoo removal processes to facilitate growth
  • 8.2.3 HAIR REMOVAL
    • 8.2.3.1 Growing adherence to conventional beauty standards to drive market
  • 8.2.4 LIPOSUCTION
    • 8.2.4.1 Increased dominance of sedentary lifestyles to encourage growth
  • 8.2.5 OTHER NON-SURGICAL PROCEDURES
• 8.3 SURGICAL PROCEDURES
  • 8.3.1 BREAST IMPLANTS
    • 8.3.1.1 Changing aesthetic preferences to drive market
  • 8.3.2 FACELIFT & BODY LIFT PROCEDURES
    • 8.3.2.1 Increasing need to reduce visible signs of aging to expedite growth
  • 8.3.3 OTHER SURGICAL PROCEDURES

9 MEDICAL AESTHETICS MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 CLINICS, HOSPITALS, AND MEDICAL SPAS
  • 9.2.1 RISING TREND OF MEDICAL TOURISM AND PLASTIC SURGERY TO ENCOURAGE GROWTH
• 9.3 BEAUTY CENTERS
  • 9.3.1 GROWING INCLINATION TOWARD CUSTOMIZED TREATMENT TO BOOST MARKET
• 9.4 HOME CARE SETTINGS
  • 9.4.1 INCREASING FOCUS ON CONVENIENCE, TREATMENT FLEXIBILITY, AND COST SAVING TO SPUR GROWTH

10 MEDICAL AESTHETICS MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 Growing adoption of advanced treatment procedures to drive market
  • 10.2.3 CANADA
    • 10.2.3.1 Increasing preference among aging individuals for physical rejuvenation to aid growth
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Rising social acceptance of medical aesthetic procedures to stimulate growth
  • 10.3.3 UK
    • 10.3.3.1 Booming cosmetics and beauty industry to accelerate growth
  • 10.3.4 FRANCE
    • 10.3.4.1 Growing social acceptance of medical aesthetic treatments to fuel market
  • 10.3.5 ITALY
    • 10.3.5.1 Growing adoption of surgical procedures among young females to boost market
  • 10.3.6 SPAIN
    • 10.3.6.1 Increasing availability of safe and minimally invasive treatments to augment growth
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 JAPAN
    • 10.4.2.1 Rising awareness for body contouring treatments to sustain growth
  • 10.4.3 CHINA
    • 10.4.3.1 Increased availability of cosmetic surgery apps and online services to aid growth
  • 10.4.4 INDIA
    • 10.4.4.1 Increasing disposable incomes to contribute to market growth
  • 10.4.5 AUSTRALIA
    • 10.4.5.1 Favorable government initiatives to promote growth
  • 10.4.6 SOUTH KOREA
    • 10.4.6.1 Booming medical tourism to speed up growth
  • 10.4.7 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 Expanding target population base to expedite growth
  • 10.5.3 MEXICO
    • 10.5.3.1 Increasing inflow of medical tourists to favor growth
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.6.2 GCC COUNTRIES
    • 10.6.2.1 Favorable government policies to propel market.
  • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 OVERVIEW
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL AESTHETICS MARKET
• 11.3 REVENUE ANALYSIS, 2020-2023
• 11.4 MARKET SHARE ANALYSIS, 2023
  • 11.4.1 ENERGY-BASED AESTHETIC DEVICES MARKET
  • 11.4.2 FACIAL AESTHETIC PRODUCTS MARKET
  • 11.4.3 COSMETIC IMPLANTS MARKET
• 11.5 RANKING OF KEY MARKET PLAYERS
• 11.6 COMPANY EVALUATION MATRIX, 2023
  • 11.6.1 ENERGY-BASED AESTHETIC DEVICES MARKET
    • 11.6.1.1 Stars
    • 11.6.1.2 Emerging leaders
    • 11.6.1.3 Pervasive players
    • 11.6.1.4 Participants
  • 11.6.2 FACIAL AESTHETIC PRODUCTS MARKET
    • 11.6.2.1 Stars
    • 11.6.2.2 Emerging leaders
    • 11.6.2.3 Pervasive players
    • 11.6.2.4 Participants
  • 11.6.3 COSMETIC IMPLANTS MARKET
    • 11.6.3.1 Stars
    • 11.6.3.2 Emerging leaders
    • 11.6.3.3 Pervasive players
    • 11.6.3.4 Participants
  • 11.6.4 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 11.6.4.1 Company footprint
    • 11.6.4.2 Region footprint
    • 11.6.4.3 Product footprint
    • 11.6.4.4 Type of device footprint
    • 11.6.4.5 Procedure footprint
    • 11.6.4.6 End-user footprint
  • 11.6.5 COMPANY BENCHMARKING: STARTUPS/SMES, 2023
    • 11.6.5.1 Detailed list of key startups/SMEs
    • 11.6.5.2 Competitive benchmarking of startups/SMEs
• 11.7 COMPANY VALUATION AND FINANCIAL METRICS
• 11.8 BRAND/PRODUCT COMPARISON
• 11.9 COMPETITIVE SCENARIO
  • 11.9.1 PRODUCT LAUNCHES AND APPROVALS
  • 11.9.2 DEALS
  • 11.9.3 EXPANSIONS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 ABBVIE INC.
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products/Solutions offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Product launches and approvals
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Key strengths
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses and competitive threats
  • 12.1.2 GALDERMA
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products/Solutions offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Product launches and approvals
      • 12.1.2.3.2 Deals
      • 12.1.2.3.3 Expansions
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Key strengths
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses and competitive threats
  • 12.1.3 JOHNSON & JOHNSON SERVICES, INC.
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products/Solutions offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Product launches and approvals
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Key strengths
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses and competitive threats
  • 12.1.4 BAUSCH HEALTH COMPANIES INC.
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products/Solutions offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Product launches and approvals
    • 12.1.4.4 MnM view
      • 12.1.4.4.1 Key strengths
      • 12.1.4.4.2 Strategic choices
      • 12.1.4.4.3 Weaknesses and competitive threats
  • 12.1.5 CYNOSURE LUTRONIC
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products/Solutions offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Product launches and approvals
      • 12.1.5.3.2 Deals
    • 12.1.5.4 MnM view
      • 12.1.5.4.1 Key strengths
      • 12.1.5.4.2 Strategic choices
      • 12.1.5.4.3 Weaknesses and competitive threats
  • 12.1.6 CUTERA, INC.
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products/Solutions offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Product launches and approvals
      • 12.1.6.3.2 Deals
  • 12.1.7 MERZ PHARMA
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products/Solutions offered
    • 12.1.7.3 Recent developments
      • 12.1.7.3.1 Expansions
  • 12.1.8 LUMENIS BE LTD.
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products/Solutions offered
    • 12.1.8.3 Recent developments
      • 12.1.8.3.1 Product launches and approvals
      • 12.1.8.3.2 Deals
  • 12.1.9 FOTONA
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products/Solutions offered
    • 12.1.9.3 Recent developments
      • 12.1.9.3.1 Product launches and approvals
      • 12.1.9.3.2 Expansions
  • 12.1.10 AEROLASE CORP.
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products/Solutions offered
    • 12.1.10.3 Recent developments
      • 12.1.10.3.1 Product launches and approvals
  • 12.1.11 SCITON
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products/Solutions offered
    • 12.1.11.3 Recent developments
      • 12.1.11.3.1 Product launches and approvals
  • 12.1.12 BOHUS BIOTECH AB
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products/Solutions offered
  • 12.1.13 RECOSMO
    • 12.1.13.1 Business overview
    • 12.1.13.2 Products/Solutions offered
  • 12.1.14 SHARPLIGHT TECHNOLOGIES INC.
    • 12.1.14.1 Business overview
    • 12.1.14.2 Products/Solutions offered
    • 12.1.14.3 Recent developments
      • 12.1.14.3.1 Product launches and approvals
  • 12.1.15 CANDELA CORPORATION
    • 12.1.15.1 Business overview
    • 12.1.15.2 Products/Solutions offered
    • 12.1.15.3 Recent developments
      • 12.1.15.3.1 Product launches and approvals
      • 12.1.15.3.2 Deals
  • 12.1.16 ALMA LASERS
    • 12.1.16.1 Business overview
    • 12.1.16.2 Products/Solutions offered
    • 12.1.16.3 Recent developments
      • 12.1.16.3.1 Product launches and approvals
      • 12.1.16.3.2 Deals
  • 12.1.17 EL.EN. S.P.A.
    • 12.1.17.1 Business overview
    • 12.1.17.2 Products/Solutions offered
    • 12.1.17.3 Recent developments
      • 12.1.17.3.1 Product launches and approvals
  • 12.1.18 INMODE LTD.
    • 12.1.18.1 Business overview
    • 12.1.18.2 Products/Solutions offered
    • 12.1.18.3 Recent developments
      • 12.1.18.3.1 Product launches and approvals
  • 12.1.19 VENUS CONCEPT
    • 12.1.19.1 Business overview
    • 12.1.19.2 Products/Solutions offered
    • 12.1.19.3 Recent developments
      • 12.1.19.3.1 Product launches and approvals
  • 12.1.20 GC AESTHETICS
    • 12.1.20.1 Business overview
    • 12.1.20.2 Products/Solutions offered
    • 12.1.20.3 Recent developments
      • 12.1.20.3.1 Product launches and approvals
      • 12.1.20.3.2 Deals
• 12.2 OTHER COMPANIES
  • 12.2.1 EVOLUS, INC.
  • 12.2.2 ASCLEPION LASER TECHNOLOGIES
  • 12.2.3 ASTANZA LASER
  • 12.2.4 APYX MEDICAL
  • 12.2.5 HUADONG MEDICINE CO., LTD.
  • 12.2.6 MEDYTOX INC.
  • 12.2.7 POLYTECH HEALTH & AESTHETICS GMBH
  • 12.2.8 REVANCE AESTHETICS
  • 12.2.9 PHOTOMEDEX
  • 12.2.10 2L BIO CO., LTD.

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS